OTC Markets Stock News
Biotech
-
4.1KWill Biogen Now Buy Anavex Life Sciences?
Last week’s negative FDA advisory committee vote may be the final nail in the coffin in the up-and-down registration path of Biogen...
-
4.8K1CytoDyn (OTCMKTS: CYDY) Accelerates Recruitment to 250 Patients in Pivotal COVID-19 Trial
CytoDyn Inc. (OTCMKTS:CYDY) on a conference call yesterday revealed that approximately 250 patients have been recruited in their CD12 severe to critical...
-
6.3K2Relief Therapeutics: Buy the Dip
Relief Therapeutics and its shareholders have had a tough couple of days. This came as fear, uncertainty, and doubt (FUD) spread throughout...
-
1.9KSPOM Stock Ready To Make Another Big Move
The only reason to trade penny stocks is for the explosive moves they can make. If a penny stock doesn’t have triple-digit...
-
2.1KIPIX Stock Gearing Up For A Major Move
IPIX Stock is gearing up for a major move after receiving a Pre-IND response from the FDA on its planned clinical trial. This...
-
2.6KRevive Therapeutics: Buy the Dip
Revive Therapeutics remains one of the most undervalued companies trading on the OTC Markets. We first covered Revive in September when shares...
-
5.0KHumanigen An Under The Radar COVID-19 Play
Humanigen is the Rodney Dangerfield of the Biotech world. The company just cannot get any respect. A big part is that many...
-
5.5KAVXL Stock Ready To Make A Big Move
AVXL stock was a big winner for us here at Insider Financial back in 2015 when we caught the run from $1 to...
-
10.0KHandicapping CytoDyn’s (OTCMKTS: CYDY) Interim Readout
Powerful recommendation from DSMB Imminent on Leronlimab Numbers are not part of any Interim report unless a statistical penalty is taken A...
